Evan Seigerman
Stock Analyst at BMO Capital
(4.70)
# 778
Out of 5,065 analysts
1103
Total ratings
55.8%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Reiterated: Buy | $100 → $120 | $78.93 | +52.03% | 32 | Oct 19, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $300 | $282.68 | +6.13% | 30 | Oct 12, 2026 | |
| AMGN Amgen | Reiterated: Hold | $450 → $415 | $424.94 | -2.34% | 73 | Oct 12, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $310 | $155.81 | +98.96% | 1 | Oct 12, 2026 | |
| BIIB Biogen | Reiterated: Hold | $220 | $233.48 | -5.77% | 65 | Oct 12, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 | $58.83 | +1.99% | 72 | Oct 12, 2026 | |
| BNTX BioNTech SE | Reiterated: Hold | $105 | $89.21 | +17.70% | 19 | Oct 12, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $174 | $153.07 | +13.67% | 82 | Oct 12, 2026 | |
| INCY Incyte | Reiterated: Hold | $130 | $113.25 | +14.79% | 56 | Oct 12, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,400 | $1,240.34 | +12.87% | 123 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $143.63 | +18.36% | 54 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $190 → $150 | $136.98 | +9.51% | 49 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $40 | $38.42 | +4.11% | 61 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $29.44 | +18.89% | 57 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $920 | $782.04 | +17.64% | 81 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $30 | $23.12 | +29.76% | 20 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $40.24 | +108.75% | 14 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 | $501.95 | +19.53% | 73 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.05 | +81.00% | 35 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $178 | $134.44 | +32.40% | 6 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.93 | +25.73% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.00 | +150.00% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 → $43.00 | $31.84 | +35.05% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $22.01 | +558.79% | 21 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.94 | +255.33% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $34 | $19.80 | +71.72% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.26 | n/a | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.17 | n/a | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.89 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €117.54 → €133.57 | €144.35 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.21 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.48 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $27 | $4.00 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 → $15 | $11.94 | n/a | 6 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €135.00 → €129.00 | €26.46 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $1.08 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $3.33 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $169 → $220 | $29.79 | n/a | 2 | Feb 24, 2020 |
Disc Medicine
Oct 19, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $78.93
Upside: +52.03%
AbbVie
Oct 12, 2026
Reiterated: Buy
Price Target: $300
Current: $282.68
Upside: +6.13%
Amgen
Oct 12, 2026
Reiterated: Hold
Price Target: $450 → $415
Current: $424.94
Upside: -2.34%
Axsome Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $310
Current: $155.81
Upside: +98.96%
Biogen
Oct 12, 2026
Reiterated: Hold
Price Target: $220
Current: $233.48
Upside: -5.77%
Bristol-Myers Squibb Company
Oct 12, 2026
Reiterated: Hold
Price Target: $60
Current: $58.83
Upside: +1.99%
BioNTech SE
Oct 12, 2026
Reiterated: Hold
Price Target: $105
Current: $89.21
Upside: +17.70%
Gilead Sciences
Oct 12, 2026
Reiterated: Buy
Price Target: $174
Current: $153.07
Upside: +13.67%
Incyte
Oct 12, 2026
Reiterated: Hold
Price Target: $130
Current: $113.25
Upside: +14.79%
Eli Lilly and Company
Oct 12, 2026
Reiterated: Buy
Price Target: $1,400
Current: $1,240.34
Upside: +12.87%
Oct 12, 2026
Reiterated: Buy
Price Target: $170
Current: $143.63
Upside: +18.36%
Oct 12, 2026
Reiterated: Hold
Price Target: $190 → $150
Current: $136.98
Upside: +9.51%
Oct 12, 2026
Reiterated: Hold
Price Target: $47 → $40
Current: $38.42
Upside: +4.11%
Oct 12, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $29.44
Upside: +18.89%
Oct 12, 2026
Reiterated: Buy
Price Target: $920
Current: $782.04
Upside: +17.64%
Oct 12, 2026
Reiterated: Buy
Price Target: $24 → $30
Current: $23.12
Upside: +29.76%
Oct 12, 2026
Reiterated: Buy
Price Target: $84
Current: $40.24
Upside: +108.75%
Oct 12, 2026
Reiterated: Buy
Price Target: $600
Current: $501.95
Upside: +19.53%
Sep 10, 2026
Reiterated: Buy
Price Target: $20
Current: $11.05
Upside: +81.00%
Aug 30, 2026
Reiterated: Buy
Price Target: $178
Current: $134.44
Upside: +32.40%
Aug 17, 2026
Reiterated: Buy
Price Target: $15
Current: $11.93
Upside: +25.73%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $8.00
Upside: +150.00%
Aug 12, 2026
Reiterated: Buy
Price Target: $39.00 → $43.00
Current: $31.84
Upside: +35.05%
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $22.01
Upside: +558.79%
Jun 30, 2026
Reiterated: Buy
Price Target: $14
Current: $3.94
Upside: +255.33%
May 11, 2026
Reiterated: Buy
Price Target: $26 → $34
Current: $19.80
Upside: +71.72%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $7.26
Upside: n/a
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $24.17
Upside: n/a
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $2.89
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: €117.54 → €133.57
Current: €144.35
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $8.21
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $4.48
Upside: n/a
Aug 13, 2021
Reiterated: Buy
Price Target: $30 → $27
Current: $4.00
Upside: n/a
Dec 16, 2020
Upgraded: Buy
Price Target: $9 → $15
Current: $11.94
Upside: n/a
Oct 16, 2020
Reiterated: Hold
Price Target: €135.00 → €129.00
Current: €26.46
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $1.08
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $3.33
Upside: n/a
Feb 24, 2020
Reiterated: Hold
Price Target: $169 → $220
Current: $29.79
Upside: n/a